Condition
Recurrent Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Lymphoma clinical trials that are recruiting, at sites in 4 countries (most in United States (4), Australia (2), Canada (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Recurrent Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Collecting blood and tissue samples for HIV/AIDS-related cancer research | — | La Jolla, California and 7 other locations | Recruiting | Dec 23, 2022 |
| CBL0137 treatment for relapsed or refractory solid tumors and CNS tumors | Phase 1/2 | Birmingham, Alabama and 34 other locations | Recruiting | May 4, 2021 |
| Using ascorbic acid with chemotherapy to treat relapsed or refractory lymphoma and related conditions | Phase 2 | Mankato, Minnesota and 3 other locations | Recruiting | Feb 1, 2018 |
| Effects of dexrazoxane on heart health in cancer survivors | — | Birmingham, Alabama and 78 other locations | Recruiting | Feb 13, 2013 |
All recruiting trials (4)
-
Collecting blood and tissue samples for HIV/AIDS-related cancer research
This study is collecting blood and tissue samples from people living with HIV and related cancers to help researchers learn more about how HIV affects cancer development.
-
CBL0137 treatment for relapsed or refractory solid tumors and CNS tumors
This study is testing a new treatment called CBL0137 to see if it can help children and young adults with tough-to-treat solid tumors and brain tumors feel better.
-
Using ascorbic acid with chemotherapy to treat relapsed or refractory lymphoma and related conditions
This study is testing if adding vitamin C to standard chemotherapy can help people with relapsed or hard-to-treat lymphomas and related blood conditions feel better.
-
Effects of dexrazoxane on heart health in cancer survivors
This study tests if the drug dexrazoxane can help protect the heart health of cancer survivors who had leukemia, lymphoma, or osteosarcoma.
Related topics
Quick answers
How many Recurrent Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (4 trials), Australia (2 trials), Canada (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.